{
    "code": "02025163",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025163",
    "time": "2019-05-24 03:04:52",
    "許可證字號": "衛署藥輸字第025163號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/03\/31",
    "發證日期": "99\/03\/31",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202516306",
    "中文品名": "絡舒利適300\/12.5毫克膜衣錠",
    "英文品名": "Co-Rasilez 300\/12.5mg Film-Coated Tablets",
    "適應症": "高血壓，Co-Rasilez適用於無法有效以aliskiren或hydrochlorothiazide單一療法控制血壓的病患。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "ALISKIRENHEMIFUMARATE,HYDROCHLOROTHIAZIDE(EQTO3,4-DIHYDROCHLOROTHIAZIDE)"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "620117Q816  台灣李氏藥業有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "FIT0320000  NOVARTIS FARMA S.P.A.",
        "製造廠廠址": "VIA PROVINCIALE SCHITO 131-80058 TORRE ANNUNZIATA, ITALY",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FIE0111000  Noden Pharma DAC",
            "製造廠廠址": "D&#39;Olier Chambers,16A D&#39;Olier Street, Dublin 2, Ireland",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2408007010",
            "成分名稱": "ALISKIREN HEMIFUMARATE",
            "含量描述": "(eq. to 300mg of aliskirn free base)",
            "含量": "331.5000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4028100600",
            "成分名稱": "HYDROCHLOROTHIAZIDE (EQ TO 3,4-DIHYDROCHLOROTHIAZIDE)",
            "含量描述": "",
            "含量": "12.5000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Co-Rasilez_中文仿單_TWI-070716-105-09-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025163&Seq=016&Type=9"
        },
        {
            "title": "Co-Rasilez 300,12.5mg FCT_Package-104-12-11(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025163&Seq=005&Type=8"
        }
    ]
}